Achieve Life Sciences, Inc. (ACHV) stock

ACHVNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31Also trades as QUIT

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 1/30

$6.72+0.34 (+5.33%)

Close on Nov 6, 2026Market cap $708.81MP/E –Yield –

Achieve Life Sciences operating margin

Operating margin is operating income as a percentage of revenue.

Achieve Life Sciences has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

See a number that looks wrong?